These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1178 related articles for article (PubMed ID: 33363544)
1. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas. Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L Front Immunol; 2020; 11():603341. PubMed ID: 33363544 [TBL] [Abstract][Full Text] [Related]
2. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas. Wu Y; Peng Z; Gu S; Wang H; Xiang W Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111 [TBL] [Abstract][Full Text] [Related]
3. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients. Hu Y; Tu Z; Lei K; Huang K; Zhu X Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238 [TBL] [Abstract][Full Text] [Related]
4. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas. Chen J; Li Y; Han X; Pan Y; Qian X Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634 [TBL] [Abstract][Full Text] [Related]
5. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma. Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618 [TBL] [Abstract][Full Text] [Related]
7. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma. Lvu W; Fei X; Chen C; Zhang B Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165 [TBL] [Abstract][Full Text] [Related]
8. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma. Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186 [TBL] [Abstract][Full Text] [Related]
9. Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction. Qian Z; Li Y; Sun Z; Fan X; Xu K; Wang K; Li S; Zhang Z; Jiang T; Liu X; Wang Y Aging (Albany NY); 2018 Oct; 10(10):2884-2899. PubMed ID: 30362964 [TBL] [Abstract][Full Text] [Related]
10. Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication. Fan Y; Peng X; Li B; Zhao G Biomed Res Int; 2020; 2020():1872962. PubMed ID: 32964017 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA. Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543 [TBL] [Abstract][Full Text] [Related]
12. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma. Xu S; Tang L; Liu Z; Luo C; Cheng Q Front Immunol; 2021; 12():731048. PubMed ID: 34659218 [TBL] [Abstract][Full Text] [Related]
14. N6-methyladenine-related genes affect biological behavior and the prognosis of glioma. Qu S; Chen Z; Liu B; Liu J; Wang H Cancer Med; 2021 Jan; 10(1):98-108. PubMed ID: 33264518 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas. Song LR; Weng JC; Huo XL; Wang L; Li H; Li D; Wu Z; Zhang JT J Neurooncol; 2020 Jan; 146(1):207-217. PubMed ID: 31853837 [TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma. Zhao J; Wang L; Wei B Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843 [TBL] [Abstract][Full Text] [Related]
17. Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma. Tan YQ; Li YT; Yan TF; Xu Y; Liu BH; Yang JA; Yang X; Chen QX; Zhang HB Front Immunol; 2020; 11():606164. PubMed ID: 33408717 [TBL] [Abstract][Full Text] [Related]
18. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas. Zhou Z; Wei J; Yang Z; Bao Y; Jiang W; Lu B; Wang W; Li L Sci Rep; 2022 Feb; 12(1):1872. PubMed ID: 35115572 [TBL] [Abstract][Full Text] [Related]
19. TGF-β Score based on Zhang W; Yan Z; Zhao F; He Q; Xu H Recent Pat Anticancer Drug Discov; 2024; 19(5):610-621. PubMed ID: 37718518 [TBL] [Abstract][Full Text] [Related]
20. Ferroptosis-related gene signature as a prognostic marker for lower-grade gliomas. Zheng Y; Ji Q; Xie L; Wang C; Yu CN; Wang YL; Jiang J; Chen F; Li WB J Cell Mol Med; 2021 Mar; 25(6):3080-3090. PubMed ID: 33594759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]